JN1532 重组人IL-35

我公司致力于为客户提供高纯度、低成本的活性重组蛋白，包括重组人IL-35在内的各类受体、细胞因子、生长因子、转录因子、激素、酶、毒性蛋白、病毒抗原等。

北京百奥莱博科技有限公司是一家专业的生物试剂销售公司。公司主要经营血清、抗原、抗体等生物试剂产品，可以为您提供专业的技术服务，以优良的价格、优质的服务、优先的理念，满足客户的各方面的需求，与国内多家企业、单位建立了良好的长期合作关系，拥有较好的企业信誉和品牌形象。 主营产品:血清、抗体、抗原、核酸提取、核酸纯化等生化试剂

特别提示：包括重组人IL-35在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人IL-35
英文名称：Recombinant Human Interleukin-35
产品货号：JN1532
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Arg21-Lys229&Arg23-Ser219在C端带有Fc标签。

IL-35质量控制：＞80%(还原性SDS-PAGE)


IL-35制剂：冻干品

IL-35保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

IL-35复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于IL-35：
Interleukin-35 is a newest and potent suppressive cytokine of the IL-12 family. Unlike other members of the IL-12 family which are produced mainly by antigen-presenting cells (APCs), IL-35 has been identified as a potentially immunosuppressive cytokine primarily produced by regulatory T (Treg) cells, and to a lesser extent by activated dendritic cells and macrophages. IL-35 is composed of the IL-12 p35 subunit and the IL-27 Epstein–Barr virus-induced protein 3 (EBI3) subunit. IL-35 plays an important role in many disease models and has been recently shown to have additional functions aside from inhibition of proliferation, including inducing its own expression in non-Treg cells.

根据您的关注的重组人IL-35，Recombinant Human Interleukin-35，重组人IL-35，rhInterleukin-35，rInterleukin-35，重组人Interleukin-35，重组Interleukin-35，JN1532，百奥莱博，，，您可能还对以下产品有需求：



名称：重组小鼠4-1BB Ligand(TNFSF9)
货号：JN0510
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Arg104-Glu309在N端带有His标签。

4-1BB Ligand/TNFSF9质量控制：＞95%(还原性SDS-PAGE)

4-1BB Ligand/TNFSF9制剂：冻干品

4-1BB Ligand/TNFSF9保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

4-1BB Ligand/TNFSF9复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于4-1BB Ligand/TNFSF9：
Tumor necrosis factor ligand superfamily member 9, also known as 4-1BBL, is a member of the the tumor necrosis factor family. Mouse 4-1BBL cDNA encodes a 309 amino acid residues (aa) protein with an 82 aa N-terminal cytoplasmic domain, a 21 aa transmembrane domain and a 206 aa C-terminal extracellular domain. The extracellular domain of 4-1BBL has a tertiary structure similar to that of other TNFSF members, but shares only low aa sequence homology (14-16%). 4-1BBL is predominantly expressed on activated antigen presenting cells (APCs) such as B cells, macrophages and dendritic cells (DCs). It is also expressed on most T and B lymphoma cell lines. TNFSF9 has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation. This cytokine has also been shown to be required for the optimal CD8 responses in CD8 T cells, and is thought to be involved in T cell-tumor cell interaction.

关注重组人IL-35，Recombinant Human Interleukin-35，重组人IL-35，rhInterleukin-35，rInterleukin-35，重组人Interleukin-35，重组Interleukin-35，JN1532，百奥莱博，，的同时，为您推荐更多您可能感兴趣的产品：


JN0216 重组小鼠碱性FGF(成纤维生长因子) 10μg|50μg|500μg|1mg
JN0222 重组人NT3(神经营养素3) 10μg|50μg|500μg|1mg
JN0364 重组人白介素IL-28B(IFN-λ3) 10μg|50μg|500μg|1mg
JN0417 重组小鼠白介素IL-2(白细胞介素2) 10μg|50μg|500μg|1mg
JN0460 重组人Fas(TNFRSF6)(CD95) 10μg|50μg|500μg|1mg
JN0472 重组小鼠TNFRSF1B 10μg|50μg|500μg|1mg
JN1137 重组人聚集素(Clusterin) 10μg|50μg|500μg|1mg

本页产品地址：http://www.geilan.com/sell/show-8530396.html